-
Diagnostics World | Medial EarlySign recently announced the results of a clinical data study in which their machine-learning based model was able to analyze Electronic Health Records and identify diabetic patients who are at the highest risk for having kidney disease within one year.
Mar 19, 2018
-
Diagnostics World | Representatives of academic institutions, pharma, and biotech companies responded to a recent survey saying that companion diagnostics are vital to personalized medicine.
Mar 16, 2018
-
STAT | The charges cap off a remarkable downfall for a once high-flying company that promised to revolutionize the blood testing industry but instead became a parable for Silicon Valley hype and hubris.
Mar 14, 2018
-
Diagnostics World Contributed Commentary | Applications like monoclonal antibodies are advancing more rapidly than ever, and the industry needs to keep pace. But the methods we have relied on for the past century to develop and produce antibodies have been plagued by low affinity, low specificity, lack of repeatability, and long production times.
Mar 13, 2018
-
Psychiatric Times |
The amyloid-β42/40 (Aβ42/40) ratio should be included as a cerebrospinal fluid (CSF) biomarker for Alzheimer disease (AD) and may be appropriate for use in the clinical diagnostic setting, according to a new study. The findings suggest that analysis of Aβ40 as well as Aβ42 concentrations may provide greater sensitivity and specificity.
Mar 9, 2018
-
Diagnostics World News While the severity of any given flu season can vary widely, the burden is always substantial—lost time, lost productivity, and lost lives. And this year’s flu season has been particularly active. The viruses are elusive, evolving from one year to the next and even changing over the course of an individual season. When the H1N1 flu virus emerged back in 2009 after the seasonal vaccine had already been developed, the strain spread and caused a global outbreak. But diagnostics also played a role.
Mar 7, 2018
-
Diagnostics World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.
Mar 6, 2018
-
The Health Care Blog |
Through a quirk of fate, the very nature of breast screening programmes has provided a wealth of digitised imaging data extremely well documented with patient outcomes. This rich source of data just so happens to be perfect for the needs of deep learning. By leveraging labelled digital images and their associated final pathological outcomes, we can provide data scientists with a near-perfect 'ground truth' dataset.
Mar 5, 2018
-
Diagnostics World | February featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Curetis, Cofactor Genomics, Inflammatix, and more.
Feb 28, 2018
-
Diagnostics World | During the 25th annual Molecular Medicine Tri-Conference in San Francisco, Leroy Hood of the Institute for Systems Biology and Providence St. Joseph Health discussed his latest efforts to transform medicine through pioneering a systems-driven approach.
Feb 27, 2018
-
Diagnostics World | Gregory Simon, President of the Biden Cancer Initiative, discussed the current state of cancer treatment during his keynote address at the 25th annual Molecular Medicine Tri-Conference last week. “What I’m going to talk to you about today,” Simon said, “is changing the way we think about what we’re doing in [cancer] research.”
Feb 23, 2018
-
Diagnostics World Contributed Commentary | From antibiotic resistance to crunched lab budgets, the challenges in diagnosing infectious diseases are stacking up. Fortunately, the latest diagnostic developments are helping to meet these demands.
Feb 23, 2018
-
Diagnostics World | Molecular medicine and diagnostics experts from around the world came to take part in the 25th annual Molecular Medicine Tri Conference. Topics covered included Digital Pathology, Molecular Diagnostics, and Molecular Diagnostics for Infectious Disease, among others.
Feb 22, 2018
-
MIT Technology Review | DNA-based scores are getting better at predicting intelligence, risks for common diseases, and more.
Feb 21, 2018
-
STAT | The most rigorous study so far found no difference in weight loss between overweight people on diets that “matched” their genotype and those on diets that didn’t.
Feb 20, 2018